An accumulating body of research indicates that PPARgamma/ligand system plays a critical role in regulation of liver regeneration and involves in non-alcoholic fatty liver disease (Yamamoto et al., 2008; Cheng et al., 2018; Zhang L. et al., 2024). Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.